Collegium Pharmaceutical Inc (COLL)

Current ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Total current assets	US$ in thousands	537,600	537,086	537,297	498,300	419,989	405,216	409,774	363,638	315,543	363,238	318,532	296,311	277,888	262,132	250,813	223,675	255,720	249,785	244,563	233,843
Total current liabilities	US$ in thousands	457,915	464,612	435,058	412,702	433,726	414,497	415,094	373,573	279,566	268,973	226,843	230,168	239,451	242,437	252,111	244,374	201,765	201,483	196,272	188,885
Current ratio		1.17	1.16	1.24	1.21	0.97	0.98	0.99	0.97	1.13	1.35	1.40	1.29	1.16	1.08	0.99	0.92	1.27	1.24	1.25	1.24

December 31, 2023 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $537,600K ÷ $457,915K
= 1.17

The current ratio of Collegium Pharmaceutical Inc has shown an improving trend over the past eight quarters, with values ranging from 0.97 to 1.24. This ratio indicates the company's ability to cover its short-term obligations with its current assets. The most recent value of 1.17 in Q4 2023 suggests that the company's current assets are 1.17 times higher than its current liabilities, which indicates a satisfactory liquidity position. Overall, Collegium Pharmaceutical Inc has been effectively managing its short-term obligations in recent quarters, as reflected in the upward trend of its current ratio.